Cargando…

Treatments for Severe Cutaneous Adverse Reactions

Severe cutaneous adverse reaction (SCAR) is life-threatening. It consists of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and generalized bullous fixed drug eruptions (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yung-Tsu, Chu, Chia-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763067/ https://www.ncbi.nlm.nih.gov/pubmed/29445753 http://dx.doi.org/10.1155/2017/1503709

Ejemplares similares

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Differential cytokine/chemokine profiles and reactivation of human herpes viruses in various forms of cutaneous adverse drug reactions. A comparative study in Taiwan
por: Chu, Chia-Yu, et al.
Publicado: (2014)

Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
por: Cho, Yung-Tsu, et al.
Publicado: (2022)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)
por: Kuijper, E.C., et al.
Publicado: (2020)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
por: Yang, Min-Suk, et al.
Publicado: (2019)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint
por: Shafiq, Nusrat, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
por: De Luca, Fabrizio, et al.
Publicado: (2017)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
por: Hoosen, Koraisha, et al.
Publicado: (2019)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
por: Kang, Min-Gyu, et al.
Publicado: (2019)

The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions
por: Nicholas, Rajam, et al.
Publicado: (2021)

Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond
por: Nguyen, Dinh Van, et al.
Publicado: (2019)

Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ppdiibsodh0bq33p3gb08lk1tf